Skip to main content
. 2016 Aug 2;11(8):e0160485. doi: 10.1371/journal.pone.0160485

Fig 6. Meta-analysis of the overall treatment-related adverse events associated with nivolumab.

Fig 6

Patients treated with nivolumab had a lower incidence of adverse events.